CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway

CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice

(2015) Guangzhi Chen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

CYP2J2 Targeting to Endothelial Cells Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet by Reprogramming Adipocyte Phenotype

(2014) Nader G. Abraham et al.   HYPERTENSION

Cardiac-Specific Overexpression of CYP2J2 Attenuates Diabetic Cardiomyopathy in Male Streptozotocin-Induced Diabetic Mice

(2013) Ben Ma et al.   ENDOCRINOLOGY

CYP2J3 Gene Delivery Up-Regulated Adiponectin Expression via Reduced Endoplasmic Reticulum Stress in Adipocytes

(2013) Xizhen Xu et al.   ENDOCRINOLOGY

Inhibitory Effects ofChung Hun Wha Dam Tang(CHWDT) on High-Fat Diet-Induced Obesity via AMP-Activated Protein Kinase Activation

(2012) Md. Jamal Uddin et al.   Evidence-based Complementary and Alternative Medicine

Cyanidin-3-O-β-glucoside regulates fatty acid metabolism via an AMP-activated protein kinase-dependent signaling pathway in human HepG2 cells

(2012) Honghui Guo et al.   Lipids in Health and Disease

Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK

(2012) Yucun Niu et al.   PLoS One

Inhibition of Soluble Epoxide Hydrolase Attenuates High-Fat-Diet–Induced Hepatic Steatosis by Reduced Systemic Inflammatory Status in Mice

(2012) Yan Liu et al.   PLoS One

Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats

(2011) Tienian Zhu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

meso-Dihydroguaiaretic Acid Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein Kinase in Human HepG2 Cells

(2011) Myoung-Su Lee et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

CYP2J3 Gene Delivery Reduces Insulin Resistance via Upregulation of eNOS in Fructose-treated Rats

(2011) Xizhen Xu et al.   Cardiovascular Diabetology

Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice

(2011) Guangzhi Chen et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels

(2011) Komal Sodhi et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

The Role of Triglycerides in Atherosclerosis

(2011) Beatriz G. Talayero et al.   Current Cardiology Reports

Increased CYP2J3 Expression Reduces Insulin Resistance in Fructose-Treated Rats and db/db Mice

(2010) X. Xu et al.   DIABETES

Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice

(2010) Craig R. Lee et al.   FASEB JOURNAL

Cordycepin Prevents Hyperlipidemia in Hamsters Fed a High-Fat Diet via Activation of AMP-Activated Protein Kinase

(2010) Peng Guo et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

An Improved Method for Determining Medium- and Long-Chain FAMEs Using Gas Chromatography

(2010) Zhidong Xu et al.   LIPIDS

Lipogenesis Is Decreased by Grape Seed Proanthocyanidins According to Liver Proteomics of Rats Fed a High Fat Diet

(2010) Isabel Baiges et al.   MOLECULAR & CELLULAR PROTEOMICS

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

(2008) Catherine Postic et al.   JOURNAL OF CLINICAL INVESTIGATION

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

(2008) Min-Chul Cho et al.   PPAR Research